In vitro aerosol characterization of Staccato® Loxapine

International Journal of Pharmaceutics

Volumn 403, Issue 1-2, 2011, Pages 101-108

  Dinh, Khe ^a   Myers, Dan J ^a   Glazer, Marc ^a   Shmidt, Tamara ^a   Devereaux, Caitlin ^a   Simis, Kathleen ^a   Noymer, Peter D ^a   He, Min ^a   Choosakul, Corinna ^a   Chen, Qiang ^a   Cassella, James V ^a  

^a Alexza Pharmaceuticals   (United States)

Author keywords

Aerosol; Characterization; Emitted dose; Particle size; Purity

Indexed keywords

LOXAPINE;

AEROSOL; AIRFLOW; ALTITUDE; ARTICLE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG PURITY; ENVIRONMENTAL TEMPERATURE; FLOW RATE; HUMIDITY; LIGHT EXPOSURE; MECHANICAL STRESS; ORIENTATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PRODUCTIVITY; VIBRATION;

AEROSOLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EQUIPMENT DESIGN; HUMIDITY; LOXAPINE; METERED DOSE INHALERS; PARTICLE SIZE;

EID: 78650175544     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.10.030     Document Type: Article

References (27)

1. A.H.De. Boer, D. Gjaltema, and P. Hagedoom Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. Part 2. Effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers Int. J. Pharm. 1996 45 56
2. K. Dinh, D. Myers, P. Noymer, and J. Cassella In vitro aerosol deposition in the oropharyngeal region for Staccato Loxapine J. Aerosol. Med. 23 2010 253 260
3. FDA Guidance for Industry: Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products - Chemistry, Manufacturing and Controls Documentation 1998 US Food and Drug Administration Center for Drug Evaluation and Research
4. ® pulmonary insulin delivery system Diabetes Technol. Ther. 9 2007 S16 S27
5. W.C. Hinds Aerosol Technology: Properties, Behavior and Measurements of Airborne Particles 1999 John Wiley & Sons, Inc. New York
6. ICH, 2006. Harmonized Tripartite Guideline: Impurities in New Drug Products Q3B(R2). International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.
7. IEC/EN 60068-2-6, 2007. Environmental Testing - Part 2-6. Tests - Test Fc: vibration (sinusoidal), Edition 7.0.
8. IEC/EN 60068-2-27, 2008a. Environmental Testing - Part 2-27: Tests - Test Ea and guidance: shock, Edition 4.0.
9. IEC/EN 60068-2-64, 2008. Environmental Testing - Part 2-64: Tests - Test Fh: vibration, broadband random and guidance.
10. IEC/EN 60601-1, 2005. Medical Electrical Equipment - Part 1. General Requirements for Basic Safety and Essential Performance, Edition 3.0.
11. R.N. Jashnani, P.R. Byron, and R.N. Dalby Testing of dry powder aerosol formulations in different environmental conditions Int. J. Pharm. 113 1995 123 130
12. R.N. Jashnani, and P.R. Byron Dry powder aerosol generation in different environments: performance comparisons of albuterol, albuterol sulfate, albuterol adipate and albuterol stearate Int. J. Pharm. 130 1996 13 24
13. J. Lenney, J.A. Innes, and G.K. Crompton Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices Respir. Med. 94 2000 496 500
14. Lesem, M.D., Tran-Johnson, T.K., Riesenberg, R.A., Feifel, D.A, Allen, M.A., Fishman, R.S., Spyker, D.A., Kehne, J.H., Cassella, J.V., in press. Rapid acute treatment of agitation in patients with schizophrenia: results of a multicenter, randomized, placebo-controlled study of inhaled loxapine. Br. J. Psychiatry.
15. A. Malton, B.S. Sumby, and Y. Dandiker A comparison of in vitro drug delivery from salbutamol Diskus and terbutaline Turbohaler inhalers J. Pharm. Med. 6 1996 35 48
16. A.R. Martin, and W.H. Finlay The effect of humidity on the size of particles delivered from metered-dose inhalers Aerosol Sci. Technol. 39 2005 283 289
17. B.J. Meakin, J.M. Cainey, and P.M. Woodcock Drug delivery characteristics of Bricanyl Turbohaler dry powder inhalers Int. J. Pharm. 119 1995 91 102
18. B.J. Meakin, J.M. Cainey, and P.M. Woodcock Simulated 'in-use' and 'mis-use' aspects of the delivery of terbutaline sulphate from Bricanyl Turbohaler dry powder inhalers Int. J. Pharm. 119 1995 103 108
19. D.J. Myers, R.D. Timmons, A.T. Lu, R.L. Hale, D.W. Solas, P. Soni, and J.D. Rabinowitz The effect of film thickness on thermal aerosol generation Pharm. Res. 24 2007 336 342
20. S. Newman Respiratory Drug Delivery: Essential Theory and Practice, Respiratory Drug Delivery 2009 Online/Virginia Commonwealth University Virginia
21. Noymer, P.D., Myers, D.J., Cassella, J.V., Timmons, R., in press. Assessing the temperature of thermally-generated inhalation aerosols. J. Aerosol. Med. Pulm. Deliv.
22. ® Clin. Pharm. 20 2000 25 33
23. J.D. Rabinowitz, M. Wensley, P. Lloyd, D. Myers, W. Shen, A. Lu, C. Hodges, R. Hale, D. Mufson, and A. Zaffaroni Fast onset medications through thermally generated aerosols J. Pharm. Exp. Ther. 309 2004 769 775
24. D.L. Ross, and R.K. Schultz Effect of inhalation rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products J. Aerosol Med. 9 1996 215 226
25. W. Tarsin, K.H. Assi, and H. Chrystyn In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of Budesonide and Eformoterol in a dry powder inhaler J. Aerosol Med. 17 2004 25 32
26. P. Zanen, P.I. van Spiegel, H. van der Kolk, E. Tushuizen, and R. Enthoven The effect of the inhalation flow on the performance of a dry powder inhalation system Int. J. Pharm. 81 1992 199 203
27. K. Zhu, R.B.H. Tan, W.K. Ng, S. Shen, Q. Zhou, and P. Heng Analysis of the influence of relative humidity on the moisture sorption of particles and the aerosolization process in a dry powder inhaler J. Aerosol Sci. 39 2008 510 524